GT Biopharma Promotes COO to Top Post, Effective Immediately
Mr. Cross has held the position of President and COO of GTBP since November 16, 2017. Source: BioSpace
Mr. Cross has held the position of President and COO of GTBP since November 16, 2017. Source: BioSpace
The FDA sent a warning letter to Chinese manufacturer Guangzhou Baiyunshan for failing to follow proper cleaning, validation and storage procedures at its Guangzhou, Guangdong facility. Source: Drug Industry Daily
Medtech petitioned the FDA to allow the company to submit an ANDA for generic Excedrin in which the proposed product is in a dosage form different from the reference drug.…
The U.S. Patent and Trademark Office issued two patents to French cell therapy group Cellectis for use of CRISPR technologies in T-cells. Source: Drug Industry Daily
The FDA finalized new guidance establishing co-crystals as a drug product intermediate. Source: Drug Industry Daily
In his first appearance as HHS Secretary on Capitol Hill, Alex Azar fielded questions Wednesday about the Trump administration’s plans to address the opioid crisis and drug prices. Source: Drug…
The Phase 3 program is the first trial in the JAK1 Atopic Dermatitis Efficacy and Safety global development program. Source: BioSpace
A 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide, a deadly poison, from a Merck facility in Pennsylvania. Source: BioSpace
The phase 3 IGNITE3 clinical trial enrolled 1,205 patients who were randomized 1:1 to receive IV eravacycline or ertapenem. Source: BioSpace
The stock market has been rocky recently, but overall the biotech market appears to have been comparatively stable. Source: BioSpace